Logos Global Management LP 13D and 13G filings for Keros Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-08-31 1:35 pm Purchase |
2020-08-20 | 13G | Keros Therapeutics, Inc. KROS |
Logos Global Management LP | 1,350,000 6.700% |
1,350,000 (New Position) |
Filing |